Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia

Pierre-Elian Chaghouri Norbert Benattar Sabine-Marie Castet Yoann Huguenin Chlo e James Mathieu Fiore Laboratoire d’h ematologie, CHU de Bordeaux, Pessac, Cryopep company, Montpellier, Centre de Ressources et de Comp etence des Maladies H emorragiques Constitutionnelles, CHU de Bordeaux, Bordeaux, Inserm U1034, Biology of Cardiovascular Disease, Pessac and Centre de R ef erence des Pathologies Plaquettaires Constitutionnelles, CHU de Bordeaux, Pessac, France. E-mail: mathieu.fiore@chu-bordeaux.fr

[1]  H. Kato,et al.  Recurrent soft tissue inflammation, necrotizing fascitis or Sweet syndrome, diagnostic dilemma , 2019, Clinical case reports.

[2]  A. Ortega‐Loayza,et al.  Insights Into the Pathogenesis of Sweet's Syndrome , 2019, Front. Immunol..

[3]  Y. Senis,et al.  Evaluation of the Total Thrombus-Formation System (T-TAS): application to human and mouse blood analysis Short title: Evaluation of T-TAS in assessing clot formation , 2018 .

[4]  Ting Liu,et al.  Sweet syndrome secondary to myelodysplastic syndrome mimicking necrotizing fasciitis , 2017, Annals of Hematology.

[5]  N. Katoh,et al.  Necrotizing Sweet syndrome in a patient with myelodysplastic syndrome , 2017, Clinical and experimental dermatology.

[6]  Samuel R. Barber,et al.  Necrotizing Soft Tissue Infection or Sweet Syndrome: Surgery Versus No Surgery?: A Case Report. , 2017, A & A case reports.

[7]  L. P. Samorano,et al.  Sweet Syndrome: Clinical Features, Histopathology, and Associations of 83 Cases , 2017, Journal of cutaneous medicine and surgery.

[8]  M. Kinjo,et al.  Mimicker of necrotising fasciitis with systemic inflammatory response syndrome: recurrent necrotising Sweet's syndrome associated with chronic myelogenous leukaemia , 2016, BMJ Case Reports.

[9]  Philip R. Cohen,et al.  Characteristics of Sweet Syndrome in patients with acute myeloid leukemia. , 2015, Clinical lymphoma, myeloma & leukemia.

[10]  Sewon Kang,et al.  Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses. , 2011, The American journal of pathology.

[11]  G. Lippi,et al.  Contemporary platelet function testing , 2010, Clinical chemistry and laboratory medicine.

[12]  Paul J. Harrison.  The role of PFA‐100® testing in the investigation and management of haemostatic defects in children and adults , 2005, British journal of haematology.

[13]  P. Driesch.  Sweet's syndrome (acute febrile neutrophilic dermatosis) , 1994 .

[14]  M. Belhaj,et al.  Dapsone in Sweet Syndrome , 1990, International journal of dermatology.

[15]  Philip R. Cohen,et al.  Sweet's syndrome and malignancy. , 1987, The American journal of medicine.

[16]  A. Goodfellow,et al.  SWEET'S SYNDROME AND ACUTE MYELOID LEUKÆMIA , 1979, The Lancet.

[17]  S. Raimer,et al.  Febrile neutrophilic dermatosis in acute myelogenous leukemia. , 1978, Archives of dermatology.

[18]  R. Sweet.  AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS. , 1964 .

[19]  R. Sweet.  AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS. , 1964, The British journal of dermatology.